IP Library Granted Patent US 12,268,862
Granted Patent B2
US 12,268,862 · App. 18/331,364 · Granted Apr 8, 2025

Method to extract and quantify the cardiac end diastolic point/mitral valve closing point from the HVAD estimated flow waveform

Inventors: Carlos Reyes (Davie, FL); Neethu Lekshmi Vasudevan Jalaja (Miami, FL)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61M60/538A61M60/148A61M60/422A61M2205/18A61M2205/3331A61M2230/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,268,862
App. No.
18/331,364
Granted
Apr 8, 2025
Kind
B2
Abstract

A control circuit for a sensorless implantable blood pump configured to determine mitral valve regurgitation includes processing circuitry configured to generate an estimated blood flow waveform from the sensorless implanted blood pump and generate an alert if between an end period of diastole and a beginning period of systole a measured amplitude of the estimated blood flow waveform does not include an inflection point.

Claims (32)

1. A device comprising:

processing circuitry configured to:

determine an estimated blood flow waveform based on data from a blood pump;

control the blood pump based on a slope of the estimated blood flow waveform between an end period of diastole and a beginning period of systole;

periodically determine an amplitude of the estimated blood flow waveform between the end period of diastole and the beginning period of systole; and

determine a severity of mitral regurgitation based on the amplitude of the estimated blood flow waveform.

2. The device of claim 1 , wherein to determine the estimated blood flow waveform based on the data from the blood pump, the processing circuitry is configured to determine the estimated blood flow waveform based on a current supplied to the blood pump.

3. The device of claim 1 , wherein the blood pump is a centrifugal pump.

4. The device of claim 1 , further comprising the blood pump, wherein the blood pump is configured to be electrically coupled to at least one of an implanted controller or an external controller, wherein the at least one of the implanted controller or the external controller comprises the processing circuitry.

5. The device of claim 1 , wherein the processing circuitry is configured to detect mitral valve regurgitation by at least determining the estimated blood flow waveform does not include an inflection point.

6. The device of claim 1 , wherein the processing circuitry is configured to control the blood pump by at least adjusting a speed of the blood pump based on the slope.

7. A device comprising:

processing circuitry configured to:

determine a mitral valve closing point from an estimated blood flow waveform generated based on data from a blood pump; and

control the blood pump based on the mitral valve closing point.

8. The device of claim 7 , wherein the processing circuitry is further configured to determine the estimated blood flow waveform based on a current supplied to the blood pump.

9. The device of claim 7 , wherein to control the blood pump, the processing circuitry is configured to adjust a speed of the blood pump.

10. The device of claim 7 , wherein the processing circuitry is configured to determine a relative indicator of a preload of a patient based on the estimated blood flow waveform.

11. The device of claim 10 , wherein to determine the relative indicator, the processing circuitry is configured to divide a first amplitude between the mitral valve closing point and a trough of the estimated blood flow waveform by a second amplitude between a peak of the estimated blood flow waveform and the trough of the estimated blood flow waveform, and wherein the processing circuitry is further configured to:

compare the relative indicator with a baseline preload relative indicator.

12. The device of claim 11 , wherein the baseline preload relative indicator is based on a patient not exhibiting mitral regurgitation.

13. The device of claim 11 , wherein the processing circuitry is configured to generate an alert in response to determining the relative indicator deviates from the baseline preload relative indicator by a predetermined percentage.

14. The device of claim 11 , wherein the processing circuitry is configured to increase a speed of the blood pump in response to determining the relative indicator is greater than the baseline preload relative indicator by a predetermined percentage.

15. The device of claim 14 , wherein the predetermined percentage is 5% to 15%.

16. The device of claim 11 , wherein the processing circuitry is configured to decrease a speed of the blood pump in response to determining the relative indicator is less than the baseline preload relative indicator by a predetermined percentage.

17. The device of claim 16 , wherein the predetermined percentage is 5% to 15%.

18. A device comprising:

processing circuitry configured to:

generate an estimated blood flow waveform based on current supplied to an implanted blood pump;

determine a mitral valve closing point from the estimated blood flow waveform based on an inflection point in the estimated blood flow waveform; and

adjust a speed of the implanted blood pump based on the mitral valve closing point.

19. The device of claim 18 , wherein to adjust the speed of the implanted blood pump based on the mitral valve closing point, the processing circuitry is configured to compare a first amplitude of the estimated blood flow waveform with a second amplitude of a baseline blood flow waveform.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2024
From: HEARTWARE, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 069520/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2023
From: REYES, CARLOS; VASUDEVAN JALAJA, NEETHU LEKSHMI
To: HEARTWARE, INC.
Reel/Frame 063893/0181 →
Continuity (3)
Continuation 17095096 · Nov 11, 2020
Provisional Application 62939158 · Nov 22, 2019
Related Publication 20230310836A1 · Oct 5, 2023
References Cited (18)
US 6688861B2 · Wampler · 2004 [cited by applicant]
US 7575423B2 · Wampler · 2009 [cited by applicant]
US 7976271B2 · LaRose et al. · 2011 [cited by applicant]
US 8135468B2 · Gutfinger et al. · 2012 [cited by applicant]
US 8209001B2 · Shelchuk et al. · 2012 [cited by applicant]
US 8419609B2 · Shambaugh, Jr. et al. · 2013 [cited by applicant]
US 9039595B2 · Ayre et al. · 2015 [cited by applicant]
US 11707617B2 · Reyes · 2023 [cited by examiner]
US 20080097226A1 · McConnel · 2008 [cited by applicant]
US 20140142444A1 · Ngo et al. · 2014 [cited by applicant]
US 20150174307A1 · Eckman et al. · 2015 [cited by applicant]
US 20150367048A1 · Brown et al. · 2015 [cited by applicant]
US 20180028735A1 · Demou et al. · 2018 [cited by applicant]
US 20180214696A1 · Cuchiara et al. · 2018 [cited by applicant]
US 20200197586A1 · Harjes · 2020 [cited by examiner]
International Preliminary Report on Patentability from International Application No. PCT/US2020/060661 dated May 17, 2022, 6 pp. [cited by applicant]
International Search Report and Written Opinion of International Application No. PCT/US2020/060661, dated Nov. 16, 2020, 8 pp. [cited by applicant]
Prosecution History from U.S. Appl. No. 17/095,096, filed Nov. 13, 2020 through Jun. 15, 2023, 23 pp. [cited by applicant]